Grace Therapeutics (GRCE)'s 30-day implied volatility (IV30) was 64.4% at the close on October 22, 2026, up from 62.8% the day before, against a 52-week range of 46.2% to 393.4%. Its 20-day historical volatility was 59.1%.

Key numbers

30-day implied volatility (IV30): 64.4%
IV30 52-week range: 46.2% to 393.4% (median 67.9%)
Historical volatility: 20-day 59.1%, 1-year 69.7%
Implied move by the nearest expiration: ±4.0%

Data as of October 22, 2026.

GRCE Implied Volatility (IV) vs Historical Volatility (HV)

Name: GRCE Implied Volatility
Creator: Market Chameleon